Skip to main content
. 2015 Aug 18;6(30):30212–30221. doi: 10.18632/oncotarget.4901

Figure 4. Overall survival according to CD200 MFI in CD56 negative patients, p = 0.04, a. and in CD34 negative patients, p = 0.03, b.

Figure 4